Campral (Acamprosate) – How It Works as an Alcohol Anti Addiction Medication
Campral (Acamprosate) has been a widely used alcohol anti addiction medication in Europe since the late 1980s and was approved by the U.S. Food and Drug Administration in 2004 to treat alcohol dependence and addiction in the United States. The precise cellular target of Campral is unknown, but it appears to decrease cravings primarily by restoring the balance in certain neurotransmitter pathway, most likely GABA and Glutamate.
The GABA neurotransmitter system in the brain is responsible for helping you relax, while the Glutamate neurotransmitter system in the brain causes you to get energized. When anyone drinks alcohol, it stimulates the GABA system in your brain and you become sedated and relax. At the same time the Glutamate system is suppressed. When the alcohol wears off, your excitatory system “rebounds” and you feel more irritable, agitated, and may find it difficult to sleep. Because alcohol addiction results in the development of alcohol tolerance, modifying the GABA/Glutamate systems, more alcohol must be consumed to achieve the desired results. Then when the alcohol wears off, the Glutamate system has become somewhat “turbocharged” resulting in quite severe addiction withdrawal symptoms in many cases. Alcohol Anti addiction medication is required to reconstruct a state of balance within the systems of the brain.
Enterhealth creates individualized alcohol addiction treatment and drug addiction rehabilitation plans because we know your unique situation calls for an effective one-of-a-kind solution.
Contact Enterhealth today at 800.388.4601 to schedule an admission or for more information, email us using the contact form on the left-hand side of this page.